SAB Biotherapeutics Inc.

SABS | NASDAQ

Price Alert Chart Builder DCF Calculator

$3.39

-$0.12 (-3.42%)

At close: Sep 21, 2026, 4:00 PM ET

$3.44

+$0.05 (+1.47%)

After-hours: Sep 21, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Revenue	n/a	1.32M	2.24M	23.9M	60.88M	55.24M
Cost of Revenue	3.08M	4.79M	3.75M	3.29M	1.65M	n/a
Gross Profit	-3.08M	-3.47M	-1.51M	20.61M	59.22M	55.24M
Operating Income	-48.95M	-42.91M	-38.08M	-28.92M	-13.39M	20.56M
Interest Income	1.43M	1.29M	584.97K	71.07K	23.12K	26.13K
Pretax Income	13.27M	-34.11M	-42.19M	-18.72M	-17.15M	20.12M
Net Income	13.27M	-34.11M	-42.19M	-18.74M	-17.15M	20.12M
Selling & General & Admin	14.6M	9.28M	23.8M	16.38M	17.09M	6.77M
Research & Development	34.35M	30.16M	16.52M	36.44M	57.18M	27.91M
Other Expenses	-3.08M	n/a	-3.75M	-3.29M	-1.65M	n/a
Operating Expenses	45.87M	39.44M	36.57M	49.53M	72.62M	34.68M
Interest Expense	240.66K	318.4K	315.28K	301.58K	294.46K	469.15K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	48.95M	44.23M	40.31M	52.82M	74.27M	34.68M
Income Tax Expense	n/a	n/a	n/a	25.63K	n/a	n/a
Shares Outstanding (Basic)	19.31M	9.26M	5.52M	4.35M	2.73M	2.7M
Shares Outstanding (Diluted)	61.34M	9.26M	5.52M	4.35M	2.73M	2.7M
EPS (Basic)	0.22	-3.68	-7.64	-4.31	-6.30	7.45
EPS (Diluted)	-0.79	-3.68	-7.64	-4.31	-6.30	7.45
EBITDA	16.6M	-28.99M	-38.13M	-15.12M	-15.2M	21.14M
EBIT	13.51M	-33.79M	-41.88M	-18.41M	-16.85M	20.59M
Depreciation & Amortization	3.08M	4.79M	3.75M	3.29M	1.65M	548.18K